erythromycin has been researched along with chlorhexidine in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 5 (55.56) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gebreyes, WA; Rajamohan, G; Srinivasan, VB | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Giacomini, KM; Huang, Y; Khuri, N; Kido, Y; Kosaka, A; Morrissey, KM; Sali, A; Wittwer, MB; Zhang, X; Zur, AA | 1 |
Cunliffe, WJ; Gould, DJ | 1 |
Johnson, RH; Rozanis, J | 1 |
Balanyk, TE; Sandham, HJ | 1 |
Braga, TM; Lopes, MF; Marujo, PE; Pomba, C | 1 |
Cherubini, K; de Figueiredo, MAZ; de Oliveira, SD; Garcia, MCR; Salum, FG; Teixeira, DDS | 1 |
Arunkajohnsak, S; Bunyaratavej, S; Chanyachailert, P; Kulthanachairojana, N; Kulthanan, K; Leeyaphan, C; Limphoka, P; Ongsri, P; Pattanaprichakul, P; Taychakhoonavudh, S | 1 |
1 review(s) available for erythromycin and chlorhexidine
Article | Year |
---|---|
A review of chemotherapeutic plaque control.
Topics: Anti-Bacterial Agents; Benzalkonium Compounds; Biguanides; Cetylpyridinium; Chlorhexidine; Dental Plaque; Dextranase; Drug Therapy; Erythromycin; Fluorides; Glycosides; Humans; Iodine; Kanamycin; Leucomycins; Pancreatin; Penicillins; Quaternary Ammonium Compounds; Tetracycline; Vancomycin; Xylitol | 1979 |
8 other study(ies) available for erythromycin and chlorhexidine
Article | Year |
---|---|
Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Membrane Transport Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Homology, Amino Acid | 2009 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.
Topics: Computer Simulation; Fluorescent Dyes; Organic Cation Transport Proteins; Prescription Drugs | 2013 |
The long-term treatment of acne vulgaris.
Topics: Acne Vulgaris; Adolescent; Adult; Benzoyl Peroxide; Chlorhexidine; Drug Therapy, Combination; Erythromycin; Female; Humans; Male; Tetracycline; Tretinoin | 1978 |
Development of sustained-release antimicrobial dental varnishes effective against Streptococcus mutans in vitro.
Topics: Amines; Amino Alcohols; Biguanides; Chlorhexidine; Delayed-Action Preparations; Erythromycin; Fluorides; Kinetics; Microbial Sensitivity Tests; Paint; Pharmaceutical Vehicles; Plant Extracts; Streptococcus mutans; Styrax | 1985 |
Involvement, and dissemination, of the enterococcal small multidrug resistance transporter QacZ in resistance to quaternary ammonium compounds.
Topics: Bacterial Proteins; Benzalkonium Compounds; Chlorhexidine; Drug Resistance, Multiple, Bacterial; Enterococcus; Erythromycin; Ethidium; Membrane Transport Proteins; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sequence Alignment; Sequence Analysis, Protein | 2011 |
Topical chlorhexidine, povidone-iodine and erythromycin in the repair of traumatic ulcers on the rat tongue: Clinical, histological and microbiological evaluation.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Anti-Infective Agents, Local; Chlorhexidine; Erythromycin; Oral Ulcer; Povidone-Iodine; Random Allocation; Rats; Rats, Wistar; Tongue; Wound Healing | 2018 |
Cost-effectiveness analysis and safety of erythromycin 4% gel and 4% chlorhexidine scrub for pitted keratolysis treatment.
Topics: Chlorhexidine; Cohort Studies; Cost-Benefit Analysis; Drug Administration Schedule; Erythromycin; Gels; Half-Life; Humans; Keratosis | 2019 |